Jones Hill Capital LP
Jones Hill Capital LP reported 29 holdings worth US$470M as of Jun 30, 2026 (Form 13F)
As of Jun 30, 2026 · Filed Aug 13, 2026
Jones Hill Capital LP reported 29 holdings worth US$470M as of Jun 30, 2026. Largest: Biomarin Pharmaceutical Inc., Gilead Sciences, Inc. and Arcutis Biotherapeutics, Inc. Filed Aug 13, 2026 (Form 13F).
- Holdings
- 29
- Value as reported
- US$470M
The filing in full
| Company | Shares | Value as reported | % of portfolio |
|---|
| Biomarin Pharmaceutical Inc. | 1.43M | US$81.9M | 17.4% |
| Gilead Sciences, Inc. | 343K | US$43.3M | 9.2% |
| Arcutis Biotherapeutics, Inc. | 1.09M | US$28.6M | 6.1% |
| Madrigal Pharmaceuticals, Inc. | 52,545 | US$28.2M | 6.0% |
| Bicara Therapeutics Inc. | 893K | US$26.5M | 5.6% |
| Relmada Therapeutics, Inc. | 3.66M | US$25.3M | 5.4% |
| Trevi Therapeutics, Inc. | 1.34M | US$25M | 5.3% |
| Xenon Pharmaceuticals Inc. | 368K | US$22.2M | 4.7% |
| Ani Pharmaceuticals, Inc. | 234K | US$19.4M | 4.1% |
| Amylyx Pharmaceuticals, Inc. | 894K | US$16.1M | 3.4% |
| Insmed Incorporated | 122K | US$13M | 2.8% |
| Nuvalent, Inc. | 98,442 | US$12.2M | 2.6% |
| Capricor Therapeutics, Inc. | 421K | US$10.1M | 2.2% |
| Aclaris Therapeutics, Inc. | 1.76M | US$9.31M | 2.0% |
| Immunic, Inc. | 540K | US$8.3M | 1.8% |
| Oric Pharmaceuticals, Inc. | 747K | US$8.09M | 1.7% |
| Tonix Pharmaceuticals Holding Corp. | 625K | US$7.98M | 1.7% |
| Syndax Pharmaceuticals, Inc. | 340K | US$7.43M | 1.6% |
| Olema Pharmaceuticals, Inc. | 574K | US$7.18M | 1.5% |
| Vir Biotechnology, Inc. | 659K | US$6.72M | 1.4% |
| Corbus Pharmaceuticals Holdings, Inc. | 654K | US$6.13M | 1.3% |
| Dianthus Therapeutics, Inc. | 57,100 | US$5.57M | 1.2% |
| Vertex Pharmaceuticals Incorporated | 11,123 | US$5.53M | 1.2% |
| Enliven Therapeutics, Inc. | 49,850 | US$2.53M | 0.54% |
| Phathom Pharmaceuticals, Inc. | 161K | US$1.75M | 0.37% |
| Achieve Life Sciences, Inc. | 26,760 | US$175K | 0.04% |
| Argenx Se | 0 | US$0 | 0.00% |
| Arrivent Biopharma, Inc. | 0 | US$0 | 0.00% |
| Contineum Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Entrada Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Fulcrum Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Nuvation Bio Inc. | 0 | US$0 | 0.00% |
| Oruka Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Terns Pharmaceuticals, Inc. | 0 | US$0 | 0.00% |
| Ultragenyx Pharmaceutical Inc. | 0 | US$0 | 0.00% |
| Vaxcyte, Inc. | 0 | US$0 | 0.00% |
| Veradermics, Incorporated | 0 | US$0 | 0.00% |
Source
View original at SEC
Related